MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Finance & Investment / Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.
Old Articles: <Older 30981-30990 Newer>
The Motley Fool
July 9, 2008
Rich Smith
Lockheed's Trillion-Dollar Warplane Make that a trillion -- 1,000,000,000 -- dollars that Lockheed Martin may reap from sales of its F-35 Lightning II warplane over the next 57 years. mark for My Articles 300 similar articles
The Motley Fool
July 8, 2008
David Forrest
You Must Be Invested in China If you are an investor with a long-term time horizon, you must be invested in China. Here's why. mark for My Articles 139 similar articles
The Motley Fool
July 8, 2008
Bill Mann
The World's Most Important Investor Sir John Templeton, arguably the world's most important investor, passed away this morning after a long illness. He was 95. Read about his incredible life here. mark for My Articles 18 similar articles
The Motley Fool
July 8, 2008
Brian Lawler
Blockbuster Drugs Bound for Extinction? One of the biggest classes of prescription drugs, those for diabetes treatments, faces tougher FDA standards. mark for My Articles 1511 similar articles
The Motley Fool
July 8, 2008
Brian Orelli
Now That's the Way to Spin Off a Company The two spin-off companies formed from Abraxis Pharmaceutical, APP Pharmaceuticals and Abraxis BioScience, are worth almost double the value their parent had before the sale. mark for My Articles 138 similar articles
The Motley Fool
July 8, 2008
Dan Dzombak
3 Stocks Hitting Low Notes These stocks have hit bottom. Are they ready to bounce? Take a look at: NYSE Euronext... Valero... Lloyds TSB Group plc... mark for My Articles 564 similar articles
The Motley Fool
July 8, 2008
Rick Aristotle Munarriz
EA Waiting at the Altar Electronic Arts is all set to wed Take-Two Interactive -- but has anyone asked the bride? mark for My Articles 275 similar articles
The Motley Fool
July 8, 2008
Brian Orelli
Not Teva's Forte Teva Pharmaceutical's Copaxone for multiple sclerosis fails to show a benefit at double strength. Investors take note. mark for My Articles 389 similar articles
The Motley Fool
July 8, 2008
Toby Shute
Some Scary Solar Numbers Lets take a close look at the cash flow concerns affecting these solar companies: Yingli Green Energy... JA Solar... Solarfun Power... LDK Solar... Trina Solar... mark for My Articles 616 similar articles
The Motley Fool
July 8, 2008
Dan Dzombak
3 Stocks Hitting High Notes These stocks have just hit 52-week highs: EZCORP... Exactech... Radyne... mark for My Articles 555 similar articles
<Older 30981-30990 Newer>    Return to current articles.